TARGOCID

This brand name is authorized in Austria, Brazil, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug TARGOCID contains one active pharmaceutical ingredient (API):

1 Teicoplanin UNII 4U3D3YY81M - TEICOPLANIN

Teicoplanin inhibits the growth of susceptible organisms by interfering with cell-wall biosynthesis at a site different from that affected by beta-lactams. Peptidoglycan synthesis is blocked by specific binding to D-alanyl-D-alanine residues. Read about Teicoplanin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TARGOCID Powder for solution for injection, infusion or oral solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XA02	Teicoplanin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XA Glycopeptide antibacterials
Discover more medicines within J01XA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720060071317, 576720060071417
Country: EE	Ravimiamet	Identifier(s): 1682052, 1787429
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58921, 58922
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 539510, 539528
Country: FR	Base de données publique des médicaments	Identifier(s): 60462328, 64077917, 69006105
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 41813, 41827
Country: IE	Health Products Regulatory Authority	Identifier(s): 49352, 49379
Country: JP	医薬品医療機器総合機構	Identifier(s): 6119401D1035
Country: MT	Medicines Authority	Identifier(s): MA1359/03901
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 528M94
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 31895, 33588
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6679
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100065717, 100065723, 100386730, 100386841, 100410746, 100459001
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64490001, W64490002, W64490003, W64490004
Country: SG	Health Sciences Authority	Identifier(s): 05117P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5933061H, 5933062H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809790155, 8699809790209
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/20.1.1/0337, Z/20.1.1/61, Z/34/159